Polymorphism T → C (-34 bp) of gene CYP17 promoter in greek patients with polycystic ovary syndrome

Fertility and Sterility

Volumn 71, Issue 3, 1999, Pages 431-435

  Diamanti Kandarakis, Evanthia ^a   Bartzis, Michael I ^a   Zapanti, Evangelia D ^a   Spina, Giovanna G ^a   Filandra, Fanny A ^a   Tsianateli, Thomais C ^a   Bergiele, Angeliki T ^a   Kouli, Chryssa R ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Enzyme P450c17a; Gene CYP17; Hyperandrogenism; Polycystic ovary syndrome

Indexed keywords

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BASE PAIRING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GREECE; HOMOZYGOSITY; HUMAN; HYPERANDROGENISM; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; SYNDROME; ADULT; BLOOD; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION;

DNA; STEROID 17ALPHA MONOOXYGENASE;

ADULT; ALLELES; DNA; FEMALE; GENOTYPE; GREECE; HUMANS; POINT MUTATION; POLYCYSTIC OVARY SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; STEROID 17-ALPHA-HYDROXYLASE;

EID: 0032586939     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00512-3     Document Type: Article

References (24)

1. Dunaif A., Givens J.R., Haseltine F., Merriam G.R. The polycystic ovary syndrome. 1992;Blackwell Scientific, Cambridge, MA.
2. Polson D.W., Wadsworth J., Adams J., Franks S. Polycystic ovaries - a common finding in normal women. Lancet. 1:1988;870-872.
3. Cooper H.E., Spellacy W.N., Prem K.A., Cohen W.D. Hereditary factors in Stein-Leventhal syndrome. Am J Obstet Gynecol. 100:1968;371-387.
4. Givens J.R. Familial ovarian hyperthecosis a study of two families . Am J Obstet Gynecol. 11:1971;959-972.
5. Ferriman D., Purdie A.W. The inheritance of polycystic ovarian disease and possible relationship to premature balding. Clin Endocrinol (Oxf). 11:1979;291-300.
6. Carey A.H., Chan K.L., Short F., White D.M., Williamson R., Franks S. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf). 38:1993;653-658.
7. Jahanfar S., Eden J.A., Warren P. A twin study of polycystic ovary syndrome. Fertil Steril. 63:1995;478-486.
8. Ben Shlomo I., Franks S., Adashi E.Y. The polycystic ovary syndrome nature or nurture? Fertil Steril. 63:1995;953-954.
9. Diamanti-Kandarakis E., Dunaif A. New perspectives in polycystic ovary syndrome. Trends Endocrinol Metab. 7:1996;267-271.
10. Dunaif A. Insulin resistance and the polycystic ovary syndrome mechanism and implications for pathogenesis . Endocr Rev. 18:1997;774-800.
11. Franks S. Polycystic ovary syndrome a changing perspective . Clin Endocrinol (Oxf). 31:1989;87-120.
12. Franks S. The ubiquitous polycystic ovary. J Endocrinol. 129:1991;317-319.
13. Franks S. Polycystic ovary syndrome. N Engl J Med. 333:1995;853-861.
14. Barnes R.B., Rosenfield R.L., Burstein S., Ehrmann D.A. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 320:1989;559-565.
15. Rosenfield R.L., Barnes R.B., Cara J.F., Lucky A.W. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil Steril. 53:1990;785-791.
16. Ehrmann D.A., Rosenfield R.L., Barnes R.B., Brigell D.F., Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 327:1992;157-162.
17. White D.W., Leigh A., Wilson C., Donaldson A., Franks S. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 42:1995;475-482.
18. Ibanez L., Hall J.E., Potau N., Carrascosa A., Prat A., Taylor A.E. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion evidence from GnRH agonist and human chorionic gonadotropin stimulation testing . J Clin Endocrinol Metab. 81:1996;4103-4107.
19. Carey A.H., Waterworth D., Patel K., White D., Little J., Novelli P., et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet. 3:1994;1873-1876.
20. Gharani N., Waterworth D.M., Williamson R., Franks S. 5′ Polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. [letter] J Clin Endocrinol Metab. 81:1996;4174.
21. Kadonaga J.T., Jones K.A., Tijan R. Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends Biochem Sci. 11:1986;20-23.
22. Picado-Leonard J., Miller W.L. Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20 lyase) similarity with the gene for P450c21 . DNA. 6:1987;439-448.
23. Gharani N., Waterworth D.M., Batty S., White D., Gilling-Smith C., Conway G.S., et al. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet. 6:1997;307-403.
24. Waterworth D.M., Bennett S.T., Gharani N., McCarthy M.I., Hague S., Batty S., et al. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet. 349:1997;986-990.